Trial Profile
Phase I Study of adjuvant chemotherapy for the patients resected pathological stage IA(T1>2cm) Non Small Cell Lung Cancer (SLCG0701)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Apr 2019
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 30 Dec 2016 Status changed from active, no longer recruiting to completed.
- 09 Sep 2015 Results presented at the 16th World Conference on Lung Cancer.
- 27 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.